| Literature DB >> 7984493 |
W Barcellini1, P Sacerdote, M O Borghi, G P Rizzardi, C Fain, C De Giuli Morghen, B Manfredi, A Lazzarin, P L Meroni, A E Panerai.
Abstract
We investigated beta-endorphin (BE) content in an HIV-infected cell line and in peripheral blood mononuclear cells (PBM) from HIV-positive subjects. HIV infection increased BE content in HuT78 cell line compared to uninfected cells. Accordingly, BE content was greater in HIV-positive subjects than in healthy controls, both in fresh PBM and in mitogen-stimulated or unstimulated cultured cells. Further, in PHA-stimulated cultures, BE increase was correlated with disease progression. Opioids are known to decrease immune responsiveness in vivo, and it may be that the increased BE concentrations contribute to HIV-associated immune deficiency. In HIV-positive subjects, but not in healthy controls, intracellular BE concentration was positively correlated with PHA-induced PBM proliferation. The latter data suggest an alternative explanation: that the increased BE content represents a paradoxical response of the host in an attempt to balance virus-induced immunodepression. Thus, BE may be important in fine-tuning of the immune response with its up- and downregulation dependent upon differences in immune status.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7984493 DOI: 10.1016/0196-9781(94)90028-0
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750